New drug combo aims to stop breast Cancer's second strike
Disease control
Recruiting now
This study is for people whose hormone-positive, HER2-negative breast cancer has returned in the breast or nearby lymph nodes after initial treatment. It tests if adding a drug called abemaciclib to standard hormone therapy is better at preventing the cancer from coming back or s…
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC